Peptilogics Strengthens Leadership Team with Three Strategic Appointments
Peptilogics Strengthens Leadership Team with Three Strategic Appointments - Dr. David Huang, leader in anti-infective drug development, to serve as SVP, Chief Medical Officer - Dr. Nick Nystrom, global leader in life sciences AI, to serve as SVP, Computing & Data - Nicholas Pachuda, seasoned expert in business strategy, to serve as SVP, Portfolio Strategy & Development News provided by Share this article Share this article PITTSBURGH, March 17, 2021 /PRNewswire/ --Â Peptilogics, a biotechnology platform company leveraging computational design to discover novel peptide therapeutics, announces ...
Source: prnewswire.com